Guangdong Raynovent Biotech Co., Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO20%
Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →
Open Guangdong Raynovent Biotech Co., Ltd on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| RAY1225 NCT06254261 |
P2 | Recruiting | Obesity | 270 | 2025-12-20 (+12 mo) |
| RAY1225 NCT06893016 |
P3 | Recruiting | Obesity | 640 | 2026-06-15 |
| ZSP1601 NCT05692492 |
P2 | Active, not recruiting | Nonalcoholic Steatohepatitis (NASH) | 180 | 2026-06-16 |
| RAY1225 NCT07139535 |
P3 | Not yet recruiting | T2DM | 350 | 2026-12-01 |
| RAY1225 NCT07139548 |
P3 | Not yet recruiting | T2DM | 600 | 2026-12-01 |